These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11682695)

  • 1. Effect of modified diabetic splenocytes on mice injected with splenocytes from multiple low-dose streptozotocin diabetic donors.
    Arata M; Bruno L; Pastorale C; Pagliero F; Basabe JC
    Exp Biol Med (Maywood); 2001 Nov; 226(10):898-905. PubMed ID: 11682695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function in mice injected with mononuclear splenocytes from multiple-dose streptozotocin diabetic mice.
    Arata M; Fabiano de Bruno L; Goncalvez Volpini WM; Quintans JC; D'Alessandro VG; Braun M; Basabe JC
    Proc Soc Exp Biol Med; 1994 May; 206(1):76-82. PubMed ID: 8183965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of modified diabetic splenocytes on mice injected with multiple low-dose streptozotocin.
    Pastorale C; Arata M; Caminos A; Bruno L; Basabe J; Chemes H
    Exp Biol Med (Maywood); 2002 Apr; 227(4):282-9. PubMed ID: 11910051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide generation: normalization of in vitro insulin secretion in mice with multiple low-dose streptozotocin and in mice injected with mononuclear splenocytes from diabetic syngeneic donors.
    Karabatas LM; Fabiano de Bruno L; Pastorale CF; Cullen C; Basabe JC
    Metabolism; 1996 Aug; 45(8):940-6. PubMed ID: 8769348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice.
    Karabatas LM; Pastorale C; de Bruno LF; Maschi F; Pivetta OH; Lombardo YB; Chemes H; Basabe JC
    Pancreas; 2005 May; 30(4):318-24. PubMed ID: 15841040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-protein feeding on insulin secretion in mice injected with splenocytes from diabetic mice.
    Karabatas LM; Lombardo Y; Basabe JC
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):81-6. PubMed ID: 8594623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients.
    Arata M; Fabiano de Bruno L; Goncalvez Volpini W; Gagliardi G; Quintans CJ; Basabe JC
    Metabolism; 1995 Nov; 44(11):1435-41. PubMed ID: 7476331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
    McEvoy RC; Andersson J; Sandler S; Hellerström C
    J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acid-enriched diet: effects on insulin secretion and cellular immune aggression.
    Karabatas LM; De Bruno LF; Pastorale C; Lombardo YB; Basabe JC
    Proc Soc Exp Biol Med; 2000 Jul; 224(3):159-65. PubMed ID: 10865231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.
    Liu L; Wang F; Zheng Y; Yuan X; Wang D; Zeng W; He X; Wang C; Deng S
    Transplant Proc; 2014 May; 46(4):1169-74. PubMed ID: 24815153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of acetyl-l-carnitine and nicotinamide remits the experimental diabetes in mice by multiple low-dose streptozotocin.
    Cresto JC; Fabiano de Bruno LE; Cao GF; Pastorale CF; Confalonieri N; del Carmen Camberos M; Basabe JC
    Pancreas; 2006 Nov; 33(4):403-11. PubMed ID: 17079947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in insulin secretion induced by plasma from mice injected with allogeneic lymphocytes.
    García JB; Venturino MC; Cresto JC; Pivetta OH; Basabe JC
    Horm Metab Res; 1987 Jul; 19(7):290-4. PubMed ID: 3305274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-adherent splenocytes precede the onset of diabetes in low-dose streptozotocin-treated mice.
    Feve B; Segain JP; Charbonnel B; Sai P
    Diabetologia; 1990 Jan; 33(1):9-14. PubMed ID: 2137423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.
    Paik SG; Fleischer N; Shin SI
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6129-33. PubMed ID: 6449703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro.
    Saï P; Pogu S; Ouary M
    Diabetologia; 1991 Apr; 34(4):212-7. PubMed ID: 2065856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin regulation of the expression of TNF-alpha, IFN-gamma and IL-10 by splenocytes in murine multiple low dose streptozotocin diabetes.
    Lau J; Börjesson A; Holstad M; Sandler S
    Immunol Lett; 2006 Jan; 102(1):25-30. PubMed ID: 16054232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes.
    Tekula S; Khurana A; Anchi P; Godugu C
    Biomed Pharmacother; 2018 Oct; 106():1428-1440. PubMed ID: 30119216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice.
    Zhao T; Luo D; Sun Y; Niu X; Wang Y; Wang C; Jia W
    J Mol Histol; 2018 Aug; 49(4):419-428. PubMed ID: 29675567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.